Anand K. Iyer
Anand K. Iyer publishes mostly in Endocrinology, Diabetes and Metabolism, General Health Professions and Computer Vision and Pattern Recognition, on topics such as Diabetes Management and Research, Mobile Health and mHealth Applications and Diabetes Management and Education.
- World rank
- #2,816,110 of 7,710,434 ranked researchers
- Rank in United States
- #816,373 of 1,627,098
- Works
- 24
- Citations
- 309
- Citations per work
- 12.9
What does Anand K. Iyer research?
Anand K. Iyer's work is mostly in Medicine (21%), Health Professions (15%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1147.0%
- Health Sciences935.9%
- Medicine520.8%
- Health Professions415.1%
- Physical Sciences311.4%
- Computer Science15.7%
- Engineering15.7%
- Life Sciences15.7%
- 1Endocrinology, Diabetes and Metabolism21% of their works
- 2General Health Professions9% of their works
- 3Computer Vision and Pattern Recognition6% of their works
- 4Aerospace Engineering6% of their works
- 5Molecular Biology6% of their works
- 6Health Information Management6% of their works
Research topics
- Diabetes Management and Research
- Mobile Health and mHealth Applications
- Diabetes Management and Education
- Infrared Target Detection Methodologies
- Artificial Intelligence in Healthcare
- Monoclonal and Polyclonal Antibodies Research
- Health Systems, Economic Evaluations, Quality of Life
- Digital Mental Health Interventions
Which keywords describe Anand K. Iyer's research?
The keywords of their largest research topics: Diabetes, Glycemic Control, Adherence, Mobile Health, Depression, Hypoglycemia, Insulin Therapy and Health Apps.
- Small Target
- Machine Learning
- Infrared
- Fc Receptors
- Cognitive Behavioral Therapy
- Chronic Disease
- Health Apps
- Hypoglycemia
- Mobile Health
- Glycemic Control
- Diabetes
- Adherence
- Depression
- Insulin Therapy
- mHealth
- Self-Management
- Cost-effectiveness Analysis
- Healthcare
- Internet-based Interventions
- Quality of Life
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Diabetes102 topics
- Glycemic Control102 topics
- Adherence72 topics
- Mobile Health72 topics
- Depression62 topics
- Hypoglycemia61 topic
- Insulin Therapy61 topic
- Health Apps51 topic
- mHealth51 topic
- Chronic Disease41 topic
- Self-Management41 topic
- Cognitive Behavioral Therapy21 topic
- Cost-effectiveness Analysis21 topic
- Fc Receptors21 topic
- Healthcare21 topic
- Infrared21 topic
- Internet-based Interventions21 topic
- Machine Learning21 topic
- Quality of Life21 topic
- Small Target21 topic
- Therapeutic Antibodies21 topic
Where does Anand K. Iyer work?
Anand K. Iyer's main affiliation in the publication record is CASI Pharmaceuticals (United States), United States.
How many publications and citations does Anand K. Iyer have?
OpenAlex counts 24 works and 309 citations for Anand K. Iyer, an h-index of 6, ranking #2,816,110 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anand K. Iyer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.